Literature DB >> 11269509

The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.

N Bit-Avragim1, A Perrot, L Schöls, C Hardt, F R Kreuz, C Zühlke, S Bubel, F Laccone, H P Vogel, R Dietz, K J Osterziel.   

Abstract

Friedreich's ataxia is an autosomal recessive disorder characterized by spinocerebellar degeneration. It is caused by an unstable GAA trinucleotide repeat expansion (>120 repeats) in the first intron of the frataxin gene on chromosome 9 (9q13) in both alleles. Concentric left ventricular hypertrophy has been recognized as the major cardiac manifestation of Friedreich's ataxia. Our aim was to investigate the influence of the frataxin repeat length on cardiac hypertrophy in patients with Friedreich's ataxia and in patients with hypertrophic and dilated cardiomyopathy. Thirty-one patients with Friedreich's ataxia, 86 patients with hypertrophic cardiomyopathy, 134 patients with dilated cardiomyopathy, and 32 healthy individuals without cardiac disease were analysed by electrocardiography and 2D-M-mode echocardiography. Then, the size of the frataxin repeat was determined by polymerase chain reaction (PCR) and agarose gel electrophoresis. The number of GAA repeats in patients with hypertrophic and dilated cardiomyopathy was not different from the length in patients without cardiac disease (hypertrophic cardiomyopathy, 8+/-2 repeats on GAA 1 allele and 11+/-5 repeats on GAA 2 allele; dilated cardiomyopathy, 7+/-2 repeats on GAA 1 allele and 11+/-5 repeats on GAA 2 allele; Control, 9+/-1 repeats on GAA 1 allele and 12+/-6 repeats on GAA 2 allele). The septal and posterior wall thickness of these patients was not related to the GAA repeat length. All patients with Friedreich's ataxia had two enlarged alleles with a mean GAA repeat length of 757+/-316 and 1012+/-231, respectively. The lengths of both alleles were significantly greater than the lengths in the controls (P<0.0001), patients with hypertrophic cardiomyopathy (P<0.0001) and dilated cardiomyopathy (P<0.0001). A significant correlation was revealed between interventricular septal hypertrophy and frataxin repeat length in the smaller allele. Furthermore, the ratio of septal to posterior wall thickness was significantly correlated to GAA repeat size on the smaller allele. In conclusion, the size of the GAA repeat on the smaller allele in the frataxin gene is associated with the degree of left ventricular hypertrophy in patients with Friedreich's ataxia but is not related to the severity of hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269509     DOI: 10.1007/s001090000162

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  15 in total

Review 1.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

2.  Friedreich's ataxia associated with subaortic membrane. A rare case.

Authors:  A Doğan; H Aksoy; H Simşek
Journal:  Herz       Date:  2013-05-29       Impact factor: 1.443

Review 3.  Friedreich's Ataxia: a review from a cardiology perspective.

Authors:  T Bourke; D Keane
Journal:  Ir J Med Sci       Date:  2011-08-07       Impact factor: 1.568

Review 4.  Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.

Authors:  A J Marian; L Salek; S Lutucuta
Journal:  Minerva Med       Date:  2001-12       Impact factor: 4.806

Review 5.  Cardiac transplantation in Friedreich ataxia.

Authors:  Grace Yoon; Teesta Soman; Judith Wilson; Kristen George; Seema Mital; Anne I Dipchand; Jane McCabe; William Logan; Paul Kantor
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

Review 6.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

Review 7.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

8.  Iron metabolism in mice with partial frataxin deficiency.

Authors:  Manuela M Santos; Carlos J Miranda; Joanne E Levy; Lynne K Montross; Mireille Cossée; Jorge Sequeiros; Nancy Andrews; Michel Koenig; Massimo Pandolfo
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

9.  Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia.

Authors:  Christian Wolf; Sylvia Boesch; Bernhard Metzler; Helga Weirich-Schwaiger; Thomas Trieb; Michael F H Schocke
Journal:  Mol Imaging Biol       Date:  2007-11-14       Impact factor: 3.488

10.  The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.

Authors:  Alaina Kipps; Mark Alexander; Steven D Colan; Kimberlee Gauvreau; Leslie Smoot; Lisa Crawford; Basil T Darras; Elizabeth D Blume
Journal:  Pediatr Cardiol       Date:  2008-08-21       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.